- Karen Elkins, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, USA (Co-Chair)
- Catharine (Katy) Bosio, NIAID, Rocky Mountain Labs, Hamilton, Montana, USA (Co-Chair)
- Lee-Ann Allen, University of Iowa, USA
- Wayne Conlan, National Research Council, Canada Canada (ex officio as TULISOC President)
- Roberto De Pascalis, CBER / FDA, USA
- Jason Huntley, University of Toledo, USA
- Tom Kawula, Washington State University, USA
- Karl Klose, University of Texas-San Antonio, USA
- Max Maurin, Université Grenoble Alpes, France
- Petra Oyston, Defence Science and Technology Laboratory, United Kingdom
- Jeannine Petersen, Centers for Disease Control, USA
- Marina Šantić, University of Rijeka, Croatia
- Jiri Stulik, University of Defence , Czech Republic
Session Chairs:
- Lee-Ann Allen, University of Iowa, Iowa City, United States
- Catharine Bosio, Rocky Mountain Laboratories, Hamilton, United States
- Simon Dove, Boston Childrens Hospital, Harvard Medical School, Boston United States
- Raquel Escudero, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain
- Thomas Henry, CIRI, International Center for Infectiology Research, Lyon, France
- Karl Klose, University of Texas San Antonio, San Antonio, United States
- Kiersten Kugeler, Centers for Disease Control and Prevention, Fort Collins, United States
- Helena Lindgren, Umeå University, UMEÅ, Sweden
- Max Maurin, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France
- Petra Oyston, Dstl, Salisbury, United Kingdom
- Marina Šantić, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
- Anders Sjöstedt, Umeå University, Sweden
- Terry Wu, University of New Mexico Health Sciences Center, Albuquerque, United States